
|Videos|May 18, 2017
Biosimilars Continue Trending Upward
Author(s)Lauren Santye, Assistant Editor
Jonathan Van Lare, PharmD, director of Pharmacy Advantage, discusses the growth of biosimilars in specialty pharmacy.
Advertisement
Jonathan Van Lare, PharmD, director of Pharmacy Advantage, discusses the growth of biosimilars in specialty pharmacy.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
3
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5


























